Back to Rockefeller Capital Management L.P. Rockefeller Capital Management L.P.

REGNREGN
Showing 8 of 31 quarters

Position history for Rockefeller Capital Management L.P.Rockefeller Capital Management L.P.'s holdings in REGENERON PHARMACEUTICALS

Rockefeller Capital Management L.P. holds 21,563 shares of REGN (REGENERON PHARMACEUTICALS), worth $13.4M as of 2026-Q2. The position was decreased (-24.4% shares). REGN represents 0.0% of Rockefeller Capital Management L.P.'s portfolio.

Current Value

$13.4M

Current Shares

21,563

Total Value Change

-$89.6M

Total Shares Change

-76,441

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
21,563
-24.4%
$13.4M0.0%$623.54
0
2026-Q1
Increased
28,520
+5.4%
$22M0.0%$766.66
30
2025-Q4
Increased
27,053
+4.7%
$20.9M0.0%$773.94
30
2025-Q3
Decreased
25,842
-56.4%
$14.5M0.0%$560.05
0
2025-Q2
Decreased
59,240
-12.4%
$31.1M0.0%$519.56
0
2025-Q1
Decreased
67,608
-28.6%
$42.9M0.1%$634.66
0
2024-Q4
Decreased
94,744
-3.3%
$67.5M0.2%$698.71
0
2024-Q3
Decreased
98,004
-1.1%
$103M0.3%$1,036.94
0

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used